NCT04155411 2022-07-27Dose Reduced Dasatinib (70 mg Daily) as First-line Treatment for Newly Diagnosed CML-CPShenzhen Second People's HospitalPhase 4 Unknown65 enrolled
NCT03216070 2017-07-13Low-dose Dasatinib as First-line Treatment for Chronic Myeloid LeukemiaHospital Universitario Dr. Jose E. GonzalezPhase 4 Unknown12 enrolled